Document is current
Any future updates will be listed below
-
Authors
Singh, Mahendra Pal
Gupta, Sandeep
Singh, Manish
Ambrish, C.
Kurmi, Prakash
Gangwani, Dinesh Kumar
Naganna, J.
Sethuraman, Ravikumar
Dhumal, Vrindavani
Behera, Sapan
Patel, Piyush M.
Patil, Dipak M. https://orcid.org/0009-0008-8690-3302
Lakhwani, Lalit K.
Ghadge, Pravin S.
Mehta, Suyog C.
Joglekar, Sadhna J.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01468246 at ClinicalTrials.govDocuments that mention this clinical trial
Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer
https://doi.org/10.1007/s10549-022-06810-1
Efficacy and Safety of Triple Fixed Dose Combination of Dapagliflozin + Sitagliptin + Metformin IR in Indian Patients with Type 2 Diabetes Mellitus: A Randomized, Phase 3 Study in Comparison with Dual FDC Sitagliptin + Metformin IR
https://doi.org/10.1007/s12325-025-03323-3
Fertility among young breast cancer survivors attempting pregnancy: A prospective, multicentre cohort study.
https://doi.org/10.1200/jco.2024.42.16_suppl.1518
Helping ourselves, helping others: the Young Women’s Breast Cancer Study (YWS) – a multisite prospective cohort study to advance the understanding of breast cancer diagnosed in women aged 40 years and younger (Results)
https://doi.org/10.1136/bmjopen-2023-081157
-
Funding
Funding for this research was provided by:
Sun Pharma
- License Information
-
More Information
Article History
Received: 5 June 2025
Accepted: 16 July 2025
First Online: 19 August 2025
Declarations
:
: Mahendra Pal Singh, Sandeep Gupta, Manish Singh, Ambrish C, Prakash Kurmi, Dinesh Kumar Gangwani, J Naganna, and Ravikumar Sethuraman were the study investigators and they received grants from sponsors for conducting the study at their respective sites. Dipak M Patil, Pravin S Ghadge, and Suyog C Mehta are full-time employees of Sun Pharma Laboratories Ltd. Vrindavani Dhumal, Sapan Behera, Piyush M Patel, and Lalit K Lakhwani were full-time employees of Sun Pharma Laboratories Ltd. when conducting the study. Sadhna J Joglekar was an employee at Sun Pharma when conducting this study. She is currently employed by Novartis. The views expressed in the article are authors' views and do not necessarily reflect the views or official position of Novartis.
: The study protocol was approved by institutional ethics committees at all participating sites. The sponsor ensured that all the necessary ethics reviews and approvals were obtained and that the clinical study was conducted in accordance with Good Clinical Practice (GCP) guidelines as defined by the International Council for Harmonisation (ICH), the Declaration of Helsinki, the New Drugs and Clinical Trials Rules, 2019, and the 2017 guidelines issued by the Indian Council of Medical Research. Informed consent was obtained in writing from all participants before any screening procedures took place.
